Biogen Inc
LSE:0R1B

Watchlist Manager
Biogen Inc Logo
Biogen Inc
LSE:0R1B
Watchlist
Price: 176.84 USD 0.05% Market Closed
Market Cap: 25.8B USD

Intrinsic Value

The intrinsic value of one 0R1B stock under the Base Case scenario is hidden USD. Compared to the current market price of 176.84 USD, Biogen Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

0R1B Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Biogen Inc

Intrinsic Value History
Dive into the past to invest in the future

0R1B looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if 0R1B is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about 0R1B?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is 0R1B valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Biogen Inc.

Explain Valuation
Compare 0R1B to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Biogen’s ambitious bet on Alzheimer’s treatments, particularly its contentious drug Aduhelm, has experienced regulatory hurdles and sluggish uptake, creating a risk that significant R&D investments will fail to yield commensurate returns and weigh on margins.

Bull Theses

If Biogen’s Alzheimer’s portfolio, including any follow-on therapies or next-generation products, achieves broader Medicare reimbursement and stronger clinical data, the company could capture a significant share of a vast, unmet market for neurodegenerative treatments.

Show More Less
How do you feel about BIIB?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Biogen Inc

Current Assets 8.9B
Cash & Short-Term Investments 4B
Receivables 1.9B
Other Current Assets 3.1B
Non-Current Assets 20.3B
Long-Term Investments 729.7m
PP&E 3.4B
Intangibles 15.8B
Other Non-Current Assets 312.4m
Current Liabilities 3.3B
Accounts Payable 413.1m
Accrued Liabilities 1.7B
Other Current Liabilities 1.2B
Non-Current Liabilities 7.7B
Long-Term Debt 6.3B
Other Non-Current Liabilities 1.4B
Efficiency

Free Cash Flow Analysis
Biogen Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Biogen Inc

Revenue
10.1B USD
Cost of Revenue
-2.5B USD
Gross Profit
7.6B USD
Operating Expenses
-4.7B USD
Operating Income
2.9B USD
Other Expenses
-1.3B USD
Net Income
1.6B USD
Fundamental Scores

0R1B Profitability Score
Profitability Due Diligence

Biogen Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Healthy Operating Margin
Strong 3Y Average Gross Margin
Sustainable 3Y Average Operating Margin
hidden
Profitability
Score

Biogen Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

0R1B Solvency Score
Solvency Due Diligence

Biogen Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Average Altman Z-Score
hidden
Solvency
Score

Biogen Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

0R1B Price Targets Summary
Biogen Inc

Wall Street analysts forecast 0R1B stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0R1B is 182.8 USD with a low forecast of 130.88 USD and a high forecast of 272.13 USD.

Lowest
Price Target
130.88 USD
26% Downside
Average
Price Target
182.8 USD
3% Upside
Highest
Price Target
272.13 USD
54% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BIIB is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

BIIB Insider Trading
Buy and sell transactions by insiders

0R1B News

Other Videos
What is the Intrinsic Value of one 0R1B stock?

The intrinsic value of one 0R1B stock under the Base Case scenario is hidden USD.

Is 0R1B stock undervalued or overvalued?

Compared to the current market price of 176.84 USD, Biogen Inc is hidden .

Back to Top